Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Imports: President Bush Says Decision Could Come In December

This article was originally published in The Pink Sheet Daily

Executive Summary

Bush suggests during presidential debate that he is waiting for completion of drug importation task force’s report, due in December, before making a decision on whether to allow imports. The President says there is a possibility “you’ll hear me say, ‘I think there’s a safe way to do it.’”

You may also be interested in...



Rx Import Report: Task Force May Miss Dec. 8 Deadline

CMS Administrator McClellan says the drug import task force, of which he is a member, will publish its report “as close to the deadline as possible.” The Dec. 8 deadline for delivering the report to Congress is mandated under the Medicare Modernization Act.

Rx Import Report: Task Force May Miss Dec. 8 Deadline

CMS Administrator McClellan says the drug import task force, of which he is a member, will publish its report “as close to the deadline as possible.” The Dec. 8 deadline for delivering the report to Congress is mandated under the Medicare Modernization Act.

Bush Reelection Is "Very Good" For Drug Manufacturers, GSK Says

President Bush's reelection is good for the pharmaceutical industry because of his position on prescription drug importation, GlaxoSmithKline VP-Federal Government Relations Sally Walsh said Nov. 17

Related Content

Topics

UsernamePublicRestriction

Register

MT101489

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel